Author

Richard T. Carback

Observed names: Carback III, Richard T., R. Carback, Richard Carback, Richard T Carback

Institution: Flow Pharma (United States)

Observed institution: Flow Pharma (United States)

ORCID: 0000-0002-2330-6323

Observed ORCID: 0000-0002-2330-6323

OpenAlex ID: A5032512035

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design

2020 · C.V. Herst, S. Burkholz, et al. · Vaccine · 62

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

2021 · Paul E. Harris, Trevor Brasel, et al. · Vaccines · 33

Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study

2023 · Scott R Burkholz, Charles V Herst, et al. · Vaccines · 23

Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans

2021 · Scott Burkholz, Suman Pokhrel, et al. · Infection Genetics and Evolution · 21

Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron

2023 · Scott Burkholz, Michael Rubsamen, et al. · Communications Biology · 16

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

2020 · Reid Rubsamen, Scott Burkholz, et al. · Frontiers in Pharmacology · 9

Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications

2023 · Sharon Wright, Scott Burkholz, et al. · International Journal of Molecular Sciences · 8

Code for: Increasing Cases of SARS-CoV-2 Omicron Reinfection Reveals Ineffective Post-COVID-19 Immunity in Denmark and Conveys the Need for Continued Next-Generation Sequencing

2023 · Burkholz, Scott, Rubsamen, Michael, et al. · Zenodo (CERN European Organization for Nuclear Research) · 1

Works count: 8

Citation count: 173

H-index: 7

I10-index: 5